Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2024 Jun 17;220(11):582-591.
doi: 10.5694/mja2.52312. Epub 2024 May 19.

A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline

Renuka Shanmugalingam  1   2 , Helen L Barrett  3   4 , Amanda Beech  3   4 , Lucy Bowyer  3 , Tim Crozier  5   6 , Amanda Davidson  7 , Marloes Dekker Nitert  8 , Kerrie Doyle  2 , Luke Grzeskowiak  9 , Nicole Hall  1 , Hicham Ibrahim Cheikh Hassan  10   11 , Annemarie Hennessy  2   12 , Amanda Henry  4   13 , David Langsford  14   15 , Vincent Ws Lee  16   17 , Zachary Munn  18 , Michael J Peek  19   20 , Joanne M Said  15   21 , Helen Tanner  22 , Rachel Taylor  23 , Meredith Ward  3 , Jason Waugh  24 , Linda Ly Yen  25 , Ellie Medcalf  16 , Katy Jl Bell  16 , Deonna Ackermann  16 , Robin Turner  26 , Angela Makris  1   2
Affiliations
Practice Guideline

A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline

Renuka Shanmugalingam et al. Med J Aust. .

Abstract

Introduction: Hypertensive disorders of pregnancy (HDP) affect up to 10% of all pregnancies annually and are associated with an increased risk of maternal and fetal morbidity and mortality. This guideline represents an update of the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) guidelines for the management of hypertensive disorders of pregnancy 2014 and has been approved by the National Health and Medical Research Council (NHMRC) under section 14A of the National Health and Medical Research Council Act 1992. In approving the guideline recommendations, NHMRC considers that the guideline meets NHMRC's standard for clinical practice guidelines.

Main recommendations: A total of 39 recommendations on screening, preventing, diagnosing and managing HDP, especially preeclampsia, are presented in this guideline. Recommendations are presented as either evidence-based recommendations or practice points. Evidence-based recommendations are presented with the strength of recommendation and quality of evidence. Practice points were generated where there was inadequate evidence to develop specific recommendations and are based on the expertise of the working group.

Changes in management resulting from the guideline: This version of the SOMANZ guideline was developed in an academically robust and rigorous manner and includes recommendations on the use of combined first trimester screening to identify women at risk of developing preeclampsia, 14 pharmacological and two non-pharmacological preventive interventions, clinical use of angiogenic biomarkers and the long term care of women who experience HDP. The guideline also includes six multilingual patient infographics which can be accessed through the main website of the guideline. All measures were taken to ensure that this guideline is applicable and relevant to clinicians and multicultural women in regional and metropolitan settings in Australia and New Zealand.

Keywords: Guidelines as topic; Hypertension; Pregnancy, high‐risk; Pre‐eclampsia.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abalos E, Cuesta C, Grosso AL, et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 2013; 170: 1‐7.
    1. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am J Hypertens 2008; 21: 521‐526.
    1. Wang W, Xie X, Yuan T, et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population‐based study. BMC Pregnancy Childbirth 2021; 21: 364.
    1. Thornton C, Dahlen H, Korda A, Hennessy A. The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population‐linked datasets: 2000–2008. Am J Obstet Gynecol 2013; 208: 476 e1‐e5.
    1. Australian Institute of Health and Welfare. Maternal deaths in Australia 2008–2012 [Cat. No. PER 70]. Canberra: AIHW, 2015. https://www.aihw.gov.au/reports/mothers‐babies/maternal‐deaths‐in‐austra... (viewed Jan 2024).

Publication types

Substances

LinkOut - more resources